Please login to the form below

Medical affairs - a strategic function for scientific engagement

The shift in dynamics between medical affairs and commercial teams

David Youds, CEO, Bedrock Group

The function of Medical Affairs has evolved over the years, and continues to do so at quite a pace. The traditional dynamic between Medical Affairs and Commercial teams has been one of restriction, with regulations on “promotional” activities. However, in more recent times there has been a shift towards an increasingly shared responsibility between Commercial and Medical Affairs teams based on mutual values of patient centricity, value propositions and the use of data.

Medical Affairs has always been a vital conduit of information both inwards and outwards. Partnerships between Medical Affairs and external stakeholders are invaluable and provide insights that can steer future medical strategy. The increasing focus of these external stakeholders on proactive communication  has driven Medical Affairs teams to be more forward-looking and ensure a greater understanding of the needs and preferences of their internal and external audiences.

As a result of these shifting dynamics, and in a world with better informed audiences than ever before, the scope of deliverables, availability of new technology and the relative size of medical budgets has changed. Correspondingly, strategic input from Medical Affairs is in demand now more than ever.

As has been said many times “with great power comes great responsibility”. There is increasing responsibility for Medical Affairs to be proactive, address data gaps, be patient-focused, creative, understand channel choice, and deliver behaviour change in addition to their more traditional role in medical and scientific information. This means new skills and new internal partnerships are required.

Most importantly, Medical Affairs needs to assert itself as a strategic co-leader of any pharmaceutical product. There are too many examples of sub-optimal collaboration between commercial and medical departments, often blamed on compliance and the need for ‘firewalls’. While an element of this argument holds true, with the right mindset in place and an early start on strategic alignment across internal functions, many of these barriers can be overcome. The value of this collaborative approach for health systems, and ultimately patients, is huge.

David Youds, CEO, Bedrock Group /

13th May 2020



Company Details

Bedrock Healthcare Communications

01252 240200

Contact Website

One Fleet
Ancells Road
GU51 2UN

Latest content on this profile

Thinking creatively about patient involvement in publications
Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.
Bedrock Healthcare Communications
Agility – The Bedrock Way
The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and here's why.
Bedrock Healthcare Communications
Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence
Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.
Bedrock Healthcare Communications
Two additional leadership moves also strengthen management team
Bedrock Healthcare Communications
The value medical communications bring to phase 2/3 of drug development
Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond to the unexpected.
Bedrock Healthcare Communications
Bedrock expands growing strategy and scientific teams
Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.
Bedrock Healthcare Communications